» call MORGAN & MORGAN ..tell your story… refer to chronic pain patient class action PHARMACIST STEVE June 19, 2017 by Steve Ariens
Chronic Pain Patients – Call Now
Morgan & Morgan Lawyers
Ask for the medical malpractice department.
Refer to chronic pain patient class action and tell your story. Continue reading
Lawmakers and practicing medicine without a license – Law Stack Exchange
Again and again we see lawmakers pass laws (generally in the context of abortion) that
- direct doctors to provide medically incorrect information or
- engage in acts which are medically unsound, or
- to not provide medical information beneficial to the patient.
How is this not engaging in the practice of medicine? Why are they not prosecuted for such behavior?
It turns out that lawmakers have special rights, known as legislative immunity (link to Wikipedia article with explanation), which allows them to enact laws. Continue reading
Top Scientists Revamp Standards To Foster Integrity In Research: Shots – Health News : NPR -April 11, 2017 – Heard on Morning Edition
It’s been 25 years since the National Academy of Sciences set its standards for appropriate scientific conduct, and the world of science has changed dramatically in that time. So now the academies of science, engineering and medicine have updated their standards.
The report published Tuesday, “Fostering Integrity in Research,” shines a spotlight on how the research enterprise as a whole creates incentives that can be detrimental to good research. Continue reading
Are Abuse-Deterrent Opioid Products A Double-Edged Sword? – Practical Pain Management – May 16, 2017 – By Jasmine Shah, PharmD and Ryan W Rodriguez, PharmD, BCPS
Solving the opioid epidemic is complex because of the multifactorial underlying causes. Complicating this issue is the need to maintain access to opioids for patients with chronic pain conditions for which prescription opioid analgesics are the only effective treatment.
Any attempts to mitigate opioid abuse must not have the unintended consequence of eliminating a viable treatment option for patients using opioid medications appropriately and experiencing meaningful clinical improvement. Continue reading
Database of Statutes, Regulations, & Other Policies for Pain Management – as of May 2017
This is a long list of rules & regulations that have been established to limit the use of opioids for pain management. It begins with general guidelines and then has links to every state policy as well.
Federation of State Medical Boards
- Model Policy on the Use of Opioid Analgesics in the Treatment of Chronic Pain – (PDF) – July 2013
- Model Policy for the Use of Controlled Substances for the Treatment of Pain – (PDF) – May 2004
- Position of the FSMB in Support of the Adoption of Pain Management Guidelines – (PDF) – Feb 2000
Alternative Facts on Opioid Risk | Dr. Jeffrey Fudin
While media muckrakers and anti-opioid zealots continue to fuel a fire of opiophobia and political strategists march like zombies in a parade of vote-seeking rhetoric, a simple fact remains ignored.
Morphine Equivalent Daily Dose (MEDD) equal to or above 100mg per day scores third on the risk scale for opioid-induced respiratory depression (OIRD).
Government agencies and third party payers continue to employ MEDD limits while ignoring other equally or more important factors that influence risk of opioid-related deaths, including that opioid abuse does not equal chronic opioid use in legitimate patients. Continue reading
Is It Negligent For a Doctor to Abandon a Patient? – AllLaw.com – by Andrew Suszek
When a patient is harmed by a doctor’s cessation of treatment – commonly called “patient abandonment’, or “medical abandonment” – a malpractice case may result.
A patient will often visit a doctor at a fairly distressing time, often at the height of the patient’s vulnerability.
As a result, a doctor may harm a patient merely by declining to provide treatment or by ceasing the provision of care before it is medically reasonable to do so. Continue reading
Is my doctor’s guideline for my treatment right for me? – Melissa J. Armstrong, MD | March 11, 2017
Health care guidelines are produced in ever-increasing numbers. The National Guideline Clearinghouse, a U.S.-based public website compiling summaries of “clinical practice” (health care) guidelines, has over 1,000 entries and is updated weekly. The National Institute for Health and Care Excellence in the U.K. has over 180 clinical guidelines.
Health care guidelines impact policy decisions and care for individuals. Recent research, though, suggests that the public has only a vague understanding of what guidelines are and how they are developed.
Current high-quality clinical practice guidelines, though, are anchored in a thorough review of available medical evidence.
This was certainly not the case with the CDC Guidelines (see CDC Manipulated Data to Deceive, Contradictions in CDC Guidelines, and Updated: Evidence Against CDC Opioid Guidelines) Continue reading
Docs warn that Medicare crackdown will hurt pain patients – POLITICO – By Arthur Allen – March 2017
A group of prominent pain and addiction specialists are pushing back against the federal opioid crackdown by asking CMS to withdraw a notice that would make it extremely difficult for Medicare patients to get painkiller prescriptions above a certain strength.
More than 80 physicians, including four who helped create the 2016 CDC guidelines on opioid prescribing, wrote to acting Medicare director Cynthia Tudor about the notice, which would require pharmacists to refuse prescriptions over 90 milligrams of morphine or its equivalent unless the patient first went through a complex, time-consuming review.
While the CDC guidelines caution that high doses create an overdose risk, they also state that physicians should have ultimate discretion on prescribing, and warn that it is not advisable for patients to be tapered off high doses of opioids involuntarily. Continue reading
LOST IN CHAOS: The State of Chronic Pain in 2016 – Presented by the Pain Action Alliance to Implement a National Strategy (PAINS)
In June 2011, the Institute of Medicine published Relieving Pain in America (RPA or Relieving Pain) and established as its highest priority development of a national population health plan to be completed by the end of 2012
In March 2016, the Department of Health and Human Services (HHS) published the National Pain Strategy (NPS). The NPS advanced all the recommendations made by the IOM committee and the notion that underpinned Relieving Pain, i.e., a “cultural transformation in the way pain is perceived, judged and treated” is needed.
Furthermore, the National Pain Strategy provided a plan to transition from a biomedical pain care model, i.e., one based on prescription medications, interventional procedures and surgeries, to a comprehensive bio-psychosocial chronic disease management model. Continue reading